Skip to main content

Cardinal Equity Fund, L.P.'s Form 4 filing

Guardian Pharmacy Services, Inc. (GRDN) · filed Sep 30, 2025

Accession no.
0001193125-25-225032
Filed
Sep 30, 2025
Trade date
May 27-Sep 27, 2025
Filing delay
126 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.48M. It was filed 126 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cardinal Equity Fund, L.P.CIK 0001432819Other: Member of 10% owner group

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 27, 2025Class A Common StockSSaleDisposed−270,958$20.16−$5,462,513.28200,099Direct
May 28, 2025Class A Common StockSSaleDisposed−50,305$20.16−$1,014,148.8149,794Direct
Sep 27, 2025Class A Common StockMOption exerciseAcquired+471,057–F2–620,851Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 27, 2025Class A Common StockMOption exerciseDisposed−471,057–F2–942,114Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)